EBITDA

A startup's legal victory protects its revolutionary wound care tech derived from the axolotl, paving the way for a new era in regenerative medicine.

Teledyne Micropac's new optocoupler pushes high-voltage isolation to new limits, enabling next-gen aerospace, defense, and industrial systems.

A new report reveals the risks of burnout and the strategic value of workforce well-being. For luxury brands and investors, human capital is the new frontier.

From spreadsheets to algorithms, RedCloud aims to overhaul the $14.6T FMCG market with AI. A financial turnaround now fuels its global expansion.

With a new C-suite, MarketCast is overhauling its strategy, promising a future AI platform to finally connect creative with real business outcomes.

S&P Global's latest report confirms Fluence's top-three status in the BESS market, driven by strategic execution and the surging demand for grid stability.

With a new MD for Canada, Aggreko is betting big on the surging energy needs of data centers and mining. Can new leadership turn market demand into dominance?

Backed by $18M in seed funding, 25-year-old founder Harry Gestetner is launching an AI-powered smart mattress cover to transform longevity through sleep.

A new alliance between Guardant Health and Trial Library uses AI and massive datasets to dismantle barriers, connecting more patients to vital cancer research.

Engineering giant Amentum will leverage advanced tech in a decade-long, multi-billion dollar effort to help nations combat nuclear and biological threats.

An animation streaming firm is building a massive AI supercomputer in Malaysia. Is it a visionary pivot or a high-stakes bet beyond its expertise?

Scienjoy's launch of AI Vista Live! in Dubai is more than a tech debut; it's a strategic play in a $200B digital human market. Here's why it matters.

JetBlue is opening its first lounge, BlueHouse. It's more than an amenity; it's a strategic pivot to capture premium flyers and redefine its brand.

Early results for INT230-6 show 50% fewer severe side effects, raising hopes for a treatment that could eliminate the toxic 'red devil' chemo.

Nasdaq-listed Society Pass is ditching its e-commerce roots for the AI gold rush. Is this a savvy M&A masterstroke or a risky gamble in a capital-heavy arena?

Public safety agencies are drowning in data. A new alliance brings advanced AI tools to the front lines to solve cases faster and ensure evidence integrity.

Beyond services, Charles River is building an ecosystem. We look at how its incubator nurtures startups and secures its own future in advanced medicine.

Astellas Pharma's new deal with venture studio Autobahn Labs isn't just a partnership; it's a strategic overhaul of the R&D pipeline. Here's why.

In the heart of oil country, a new boom is taking shape. New Era Energy & Digital is building a gigawatt-scale AI campus, but can it win the infrastructure race?

Senzing's acquisition of Placekey is more than a merger; it’s a bid to create a universal data language. But can an open standard thrive under corporate rule?